#USA #financial results #Belgrade #Conference Call #Xtant Medical

Xtant Medical to Unveil Q3 2026 Financial Results

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology firm dedicated to providing innovative surgical solutions for spinal and orthopedic ailments, has announced its upcoming third-quarter financial results. This announcement emphasizes the company's commitment to transparency and accountability, as it prepares to share critical financial performance metrics from the quarter ending September 30, 2026.

Announcement Details

The financial results will be published before the markets open on Monday, November 16, 2026. This timing ensures that investors and stakeholders have access to the information at the start of trading, allowing for informed decision-making based on the latest financial data. Sean Browne, the company's President and Chief Executive Officer, alongside Scott Neils, the Chief Financial Officer, will lead a conference call to discuss the results.

Conference Call Information

• - Date: November 16, 2026
• - Time: 8:30 AM ET
• - Dial-in Number: 888-506-0062 (Toll-Free)
• - International Dial-in: 973-528-0011
• - Passcode: 429466
• - Webcast Link: Join the Webcast

Those unable to join the live call will have the opportunity to access a replay, which will be available on the company's official website under the Investor Information section. This accessibility underscores Xtant Medical's commitment to keeping its investors informed, fostering trust and engagement within its investor community.

About Xtant Medical Holdings, Inc.

Founded with a mission to honor the gift of donation, Xtant Medical is devoted to enhancing patients' lives through innovative medical solutions. The company operates globally, focusing on the design, development, and commercialization of a wide range of orthobiologics products, which target chronic and surgical wound care, sports medicine, and spinal implant markets. Xtant Medical prides itself on its dedicated team of professionals who operate with integrity and a customer-centric ethos. They are not just creating products but are on a mission to improve quality of life.

Xtant Medical's portfolio includes advanced spinal implant systems and biologics that leverage the latest advancements in medical technology to ensure optimal outcomes for patients. The firm actively engages in research and development to expand its product offerings and remain at the forefront of the medical technology landscape. Their focus on surgical solutions demonstrates their commitment to addressing critical health challenges faced by individuals undergoing orthopedic procedures.

As the organization prepares for the upcoming financial results announcement, industry experts and analysts will undoubtedly be closely monitoring the company's performance indicators, trends, and forecasts. Stakeholders expect insights into sales growth, operational efficiency, and overall financial health that could influence future investments and strategies in the competitive healthcare and medical technology sectors.

In conclusion, the anticipated call and financial disclosure represent an important milestone for Xtant Medical. It will provide valuable insights into the company's performance while reinforcing its ongoing dedication to innovation, quality, and improving patient outcomes in the medical field. As Xtant Medical continues to expand its global presence and product lines, the future looks promising for both the company and the patients it serves.